- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
March 30, 2023Minnesota Attorney General Keith Ellison and Robins Kaplan Partner Tara Sutton Give Opening Statements in Minnesota’s Lawsuit Against JUUL
March 28, 2023Robins Kaplan LLP Announces 2023 Leadership Council on Legal Diversity (LCLD) Fellow and Pathfinder
March 22, 2023Benchmark Litigation Names Robins Kaplan 2023 Minnesota Law Firm of the Year
April 3, 2023Conference of Tribal Lending Commissioners
April 11-13, 2023Mass Torts Made Perfect Seminar
April 19, 2023FBA Women in MDL, Mass and Class Leadership
March 2023Unintended Consequences of Banning Noncompete Agreements
March 26, 2023What I’ll Be Watching for in the Amgen Oral Arguments
March 2023How an Investor Can Lose More Than Just Their Investment
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Attorneys, Firm Recognized by Managing Intellectual Property
March 24, 2020
Robins Kaplan LLP is pleased to announce that attorneys Jake Holdreith and Christopher Larus have been named to Managing Intellectual Property’s 2020 shortlist for Outstanding Litigator: Minnesota. Only five attorneys from the state were recognized on this list. Additionally, Robins Kaplan was one of five firms shortlisted for the “Patent Contentious: Midwest” category.
The shortlists for the Managing IP Awards are based on research conducted for the 2020 edition of IP Stars, a guide to IP firms and practitioners worldwide. Shortlist candidates are chosen based on nominations sent by firms contacted for IP Stars research, as well as interview notes, survey submissions, and Managing Intellectual Property’s own independent research.
Holdreith is a member of the firm’s executive board and a well-known strategist, trusted counselor and able courtroom lawyer. Over the course of his career, Holdreith has established himself as an innovative go-to patent litigator for generic pharmaceutical makers and technology companies alike. Holdreith has obtained multiple jury verdicts for patent owners ranging from $3 million to in excess of $34 million, as well as multiple defense judgments. In 2016, he represented Collegium in obtaining judgment of invalidity of three asserted patents that resulted in lifting a stay of FDA approval and permitted the launch of XTAMPZA, an abuse deterrent pain medication. In July 2018, he and the Robins Kaplan team secured a rare ruling of non-infringement of a proposed ANDA product in a Hatch-Waxman trial over the blockbuster kidney disease drug Sensipar®.
As a leading attorney in the IP arena, Holdreith has been recognized by numerous publications for his outstanding work. He is ranked in IAM1000: The World’s Leading Patent Practitioners, has been named Minneapolis’ Intellectual Property Lawyer of the Year by Best Lawyers, a Life Sciences Star by LMG Life Sciences, a Patent and Trademark Star by Managing Intellectual Property, and in 2017 was recognized as an Intellectual Property Trailblazer by The National Law Journal.
Larus is the chair of the firm’s National Intellectual Property and Technology Litigation Group. For more than 25 years, he has helped leading technology companies protect and monetize their intellectual property. He tries complex patent, trade secret, trademark, and copyright and licensing dispute cases in courts throughout the United States in both national and international arbitration. Larus has secured numerous first chair trial victories on behalf of both plaintiffs and defendants. In 2017, Larus represented telecommunications equipment supplier PCT in a four week jury trial that led to entry of a permanent injunction prohibiting the sale of 60 separate infringing products. Larus was also trial counsel for Phillips Beverage Company in its successful defense of a $100 Million international arbitration brought by the French luxury goods maker LVMH.
Larus led the development of Robins Kaplan’s Pinpoint IP™ patent analytic software, which provides clients data-driven inputs to assist in identifying patent assets most likely to drive substantial value in licensing and enforcement. Larus has extensive experience as an arbitrator in both national and international arbitration. He serves as an appointed arbitrator in disputes before the American Arbitration Association (AAA), International Centre For Dispute Resolution (ICDR), World Intellectual Property Organization (WIPO) and China International Economic and Trade Arbitration Commission (CIETAC).
Larus has previously been named an Intellectual Property Trailblazer by The National Law Journal. He has also been named to the IAM Strategy 300: The World’s Leading IP Strategists” list and to Managing Intellectual Property’s list of Patent Stars and Trademark Stars.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.